These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 17274394)

  • 21. Ginkgo biloba special extract EGb 761 in generalized anxiety disorder and adjustment disorder with anxious mood: a randomized, double-blind, placebo-controlled trial.
    Woelk H; Arnoldt KH; Kieser M; Hoerr R
    J Psychiatr Res; 2007 Sep; 41(6):472-80. PubMed ID: 16808927
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prospective memory function in mild cognitive impairment and early dementia.
    Thompson C; Henry JD; Rendell PG; Withall A; Brodaty H
    J Int Neuropsychol Soc; 2010 Mar; 16(2):318-25. PubMed ID: 20128933
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Proof of efficacy of the ginkgo biloba special extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multi-infarct dementia.
    Kanowski S; Herrmann WM; Stephan K; Wierich W; Hörr R
    Pharmacopsychiatry; 1996 Mar; 29(2):47-56. PubMed ID: 8741021
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Facial emotion recognition deficit in amnestic mild cognitive impairment and Alzheimer disease.
    Spoletini I; Marra C; Di Iulio F; Gianni W; Sancesario G; Giubilei F; Trequattrini A; Bria P; Caltagirone C; Spalletta G
    Am J Geriatr Psychiatry; 2008 May; 16(5):389-98. PubMed ID: 18403572
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Tanakan as a multimodal cytoprotective factor in general medicine].
    Naprienko MV; Esin RG; Mukhametova ER; Esin OR; Smekalkina LV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(11):146-151. PubMed ID: 27030838
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Cognitive impairment in patients with diabetes mellitus type 2 and possibilities of its treatment].
    Khaĭrullin IKh; Esin RG; Pozdniak AO
    Zh Nevrol Psikhiatr Im S S Korsakova; 2014; 114(9):25-9. PubMed ID: 25403297
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Atrial fibrillation and risk of dementia in non-demented elderly subjects with and without mild cognitive impairment (MCI).
    Forti P; Maioli F; Pisacane N; Rietti E; Montesi F; Ravaglia G
    Arch Gerontol Geriatr; 2007; 44 Suppl 1():155-65. PubMed ID: 17317449
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of Alzheimer's disease onset with ginkgo biloba and other symptomatic cognitive treatments in a population of women aged 75 years and older from the EPIDOS study.
    Andrieu S; Gillette S; Amouyal K; Nourhashemi F; Reynish E; Ousset PJ; Albarede JL; Vellas B; Grandjean H;
    J Gerontol A Biol Sci Med Sci; 2003 Apr; 58(4):372-7. PubMed ID: 12663701
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Behavioural and psychological symptoms of dementia (BPSD): effects of EGb 761.
    Hoerr R
    Pharmacopsychiatry; 2003 Jun; 36 Suppl 1():S56-61. PubMed ID: 13130390
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuropsychological prediction of conversion to Alzheimer disease in patients with mild cognitive impairment.
    Tabert MH; Manly JJ; Liu X; Pelton GH; Rosenblum S; Jacobs M; Zamora D; Goodkind M; Bell K; Stern Y; Devanand DP
    Arch Gen Psychiatry; 2006 Aug; 63(8):916-24. PubMed ID: 16894068
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mild cognitive impairment: deficits in cognitive domains other than memory.
    Ribeiro F; de Mendonça A; Guerreiro M
    Dement Geriatr Cogn Disord; 2006; 21(5-6):284-90. PubMed ID: 16484806
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cognitive profiles in Alzheimer's disease and in mild cognitive impairment of different etiologies.
    Loewenstein DA; Acevedo A; Agron J; Issacson R; Strauman S; Crocco E; Barker WW; Duara R
    Dement Geriatr Cogn Disord; 2006; 21(5-6):309-15. PubMed ID: 16490966
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Mild cognitive impairment: a prodromal phase of dementia?].
    Jonker C; Comijs HC
    Tijdschr Gerontol Geriatr; 2007 Jul; 38(3):115-21. PubMed ID: 17642317
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rate of progression of mild cognitive impairment to dementia--meta-analysis of 41 robust inception cohort studies.
    Mitchell AJ; Shiri-Feshki M
    Acta Psychiatr Scand; 2009 Apr; 119(4):252-65. PubMed ID: 19236314
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Intellectual decline: normal or already pathological. Implementing IGeL dementia diagnosis!].
    MMW Fortschr Med; 2002 Apr; 144(15):65. PubMed ID: 12013036
    [No Abstract]   [Full Text] [Related]  

  • 36. Predictive accuracy of MCI subtypes for Alzheimer's disease and vascular dementia in subjects with mild cognitive impairment: a 2-year follow-up study.
    Rasquin SM; Lodder J; Visser PJ; Lousberg R; Verhey FR
    Dement Geriatr Cogn Disord; 2005; 19(2-3):113-9. PubMed ID: 15591801
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Safety and effectiveness of a traditional ginkgo fresh plant extract - results from a clinical trial.
    Bäurle P; Suter A; Wormstall H
    Forsch Komplementmed; 2009 Jun; 16(3):156-61. PubMed ID: 19657199
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Preliminary assessment of ginkgo biloba (Ginkofar) in patients with dementia].
    Bidzan L; Biliekiewicz A; Turczyński J
    Psychiatr Pol; 2005; 39(3):559-66. PubMed ID: 16149765
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Mild cognitive impairment].
    Gabryelewicz T; Wasiak B
    Psychiatr Pol; 2001; 35(4):647-56. PubMed ID: 11760464
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Polysomnographic effects of adjuvant ginkgo biloba therapy in patients with major depression medicated with trimipramine.
    Hemmeter U; Annen B; Bischof R; Brüderlin U; Hatzinger M; Rose U; Holsboer-Trachsler E
    Pharmacopsychiatry; 2001 Mar; 34(2):50-9. PubMed ID: 11302564
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.